LEU

LEUCINE

Find entries where: LEU

is present as a standalone ligand in 108 entries

as a non-polymer is covalently linked to polymer or other heterogen groups 27 entries

is present in a polymer sequence 212,541 entries

Find related ligands:

Similar Ligands (Stereospecific)

Similar Ligands (Quick Screen)

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	LEUCINE
Identifiers	(2S)-2-amino-4-methyl-pentanoic acid
Formula	C₆ H₁₃ N O₂
Molecular Weight	131.173
Type	L-PEPTIDE LINKING
Isomeric SMILES	CC(C)C[C@@H](C(=O)O)N
InChI	InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1
InChIKey	ROHFNLRQFUQHCH-YFKPBYRVSA-N

Chemical Details
Formal Charge	0
Atom Count	22
Chiral Atom Count	1
Bond Count	21
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00149
Name	Leucine
Groups	investigational nutraceutical
Description	An essential branched-chain amino acid important for hemoglobin formation.
Synonyms	(2S)-2-Amino-4-methylpentanoic acid L-Leucine L-Leucin 2-Amino-4-methylvaleric acid (2S)-alpha-2-Amino-4-methylvaleric acid Leucine (S)-(+)-Leucine L-Leucine hydrochloride Leu (2S)-alpha-Leucine L-Leuzin L (S)-Leucine
Brand Names	TrophAmine Aminosyn II 10% With Electrolytes Aminosyn 10% W Electrolytes ExoSCRT Derma Signal Kit SRLV Aminosyn-PF 10% Aminosyn RF Injection Smofkabiven Primene 10%-liq IV Synthamin Travasol Amino Acid Inj 5.5% Olimel 4.4% E 4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose Olimel 4.4% Aminosyn II 8.5% With 50% Dextrose 4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose Premasol - sulfite-free (Amino Acid) Aminosyn II 8.5% Injection 5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Travasol Inj Without Electrolytes 5.5% Aminosyn RF Clinimix 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Perikabiven Aminosyn 7% Aminosyn II 7% M In 10% Dextrose(dual Chamber) 2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec 4.25%travasol Amino Acid InJ.W.elecw.5%dex. Aminosyn 8.5% 4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose 2.75% Travas. Amino Acid InJ.W.elecw.25%dex Nephramine Liq IV 4.25%trav. Amino Acid InJ.W.O.elect.5%dext. Renamin (amino Acids) Injection Kabiven 2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix Aminosyn II 5% Inj Aminosyn-PF Olimel 3.3% E Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec 8.5% Freamine III Aminosyn II and Dextrose Olimel 5.7% ExoSCRT Derma Signal SRLV Vial 1. Lyophilized Plenamine Novamine Aminosyn II Smofkabiven Peripheral 5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose Nutrineal Pd4 Vamin N Smofkabiven Electrolyte Free ASCE plus Derma Signal Kit SRLV S Travasol Amino Acid Inj 8.5% FreAmine III Travasol E Travasol Vamin 18 Electrolyte-free 2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix 4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose BranchAmin Aminosyn II 7% With 10% Dextrose 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix Aminosyn II in Dextrose Clinimix E Aminosyn II 8.5% M In 20% Dextrose (dual Chamber) 4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose Aminosyn-PF 7% ASCE plus Derma Signal Kit SRLV NephrAmine Primene Aminosyn HF 20% Prosol ExoSCRT Derma Signal SRLV Vial 2. Diluent Aminosyn II 7% With 50% Dextrose 4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix ProcalAmine Aminosyn II 7% Injection Aminosyn 8.5% Injection With Electrolytes Aminosyn II with Electrolytes 2.5%travasol Amino Acid InJ.W.eleC.W.25%dex 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix Aminosyn II with Electrolytes in Dextrose with Calcium Aminosyn 4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix Olimel 5.7% E Aminosyn 5% Essepna Clinisol Aminosyn II In Dextrose Injection Aminosyn 3.5% M ProSol 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Hepatasol Primene 10% 2.75%travasol Amino Acid InJ.W.eleC.W.5%dex. Aminosyn Sulfite Free 5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose Periolimel 2.5% E Smofkabiven Extra Nitrogen HepatAmine FreAmine HBC Bcaa 4% Inj 4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix RenAmin Olimel 7.6% E Olimel 7.6% Travasol Inj Without Electrolytes 8.5% Smofkabiven Extra Nitrogen Electrolyte Free
Indication	Indicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress.
Categories	Amino Acids Amino Acids, Branched-Chain Amino Acids, Essential Amino Acids, Peptides, and Proteins Dietary Supplements Proteinogenic Amino Acids Supplements
CAS number	61-90-5

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Probable leucine--tRNA ligase, mitochondrial	MASVWQRLGFYASLLKRQLNGGPDVIKWERRVIPGCTRSIYSATGKWTKE...	unknown
Leucine carboxyl methyltransferase 2	MGPRSRERRAGAVQNTNDSSALSKRSLAARGYVQDPFAALLVPGAARRAP...	unknown
Leucine carboxyl methyltransferase 1	MATRQRESSITSCCSTSSCDADDEGVRGTCEDASLCKRFAVSIGYWHDPY...	unknown
Leucine--tRNA ligase, cytoplasmic	MAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTF...	unknown
Branched-chain-amino-acid aminotransferase, mitochondrial	MAAAALGQIWARKLLSVPWLLCGPRRYASSSFKAADLQLEMTQKPHKKPG...	unknown
Branched-chain-amino-acid aminotransferase, cytosolic	MKDCSNGCSAECTGEGGSKEVVGTFKAKDLIVTPATILKEKPDPNNLVFG...	unknown
Monocarboxylate transporter 10	MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVEL...	unknown	inhibitor
Monocarboxylate transporter 8	MALQSQASEEAKGPWQEADQEQQEPVGSPEPESEPEPEPEPEPVPVPPPE...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
PubChem	7045798, 6106
ChEMBL	CHEMBL291962
ChEBI	CHEBI:15603, CHEBI:57427
CCDC/CSD	CADPEF, CADPAB, CEGKOQ, GOWCAW, FEQYUW, GOWBUP, POVYUV, AXUTIX, DLLEUC02, ZIPCOT01, WAKYAJ, ZIPCOT, URODEL, SETTOB, VUKQAV01, GUQKEK, NOFWUA, HAGZUL, PATPUV, VUKQAV03, VUKQAV02, NOFXEL, NOFXAH, CADLEA, VUKQAV04, VUKQAV05, VUKQAV06, VUKQAV08, VUKQAV09, FITNIF, VUKQAV07, AHOHIQ, GOWBOJ, DLLEUC, KERMUP, YIGMIM, ZINDEI, DLLEUC03, VUKQAV, ZATMUG, ZATJOX, WIPQOE01, ZATNER, SAJYUB, ZATNAN
COD	4501604

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

LEU

LEUCINE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References